Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.
Líder de la industria
Los ingresos de la empresa lideran el sector. Sus ingresos anuales más recientes ascienden a 44.33B USD.
Alto dividendo
La empresa es una gran pagadora de dividendos. Su ratio de pago de dividendos más reciente es del 29.13%.
Dividendo estable
La empresa ha pagado dividendos de forma regular durante los últimos 5 años. Su ratio de pago de dividendos más reciente es del 29.13%.
Valorada de forma justa
El PE más reciente de la empresa es 26.54, en un rango percentil medio de 3 años.
Venta institucional
Las tenencias institucionales más recientes son 1.25B acciones, lo que supone una reducción del 13.03% con respecto al trimestre anterior.
En posesión de Diamond Hill Capital
El inversor estrella Diamond Hill Capital posee 6.41M acciones de este valor.